GENE ONLINE|News &
Opinion
Blog

National Institute of Allergy and Infectious Diseases
COVID-19
COVID-19 Vaccine: Moderna Begins Phase 3 COVE Study of mRNA-1273
2020-07-27
COVID-19 Baricitinib
Eli Lilly Launches Phase 3 Trial with Baricitinib for COVID-19 Patients
2020-06-26
COVID-19 Remdesivir
Remdesivir Registers Middling Benefit in Patients with Moderate COVID-19
2020-06-01
R&D Anti-HIV
Long-Acting Cabotegravir Injection Performs Better as an HIV PrEP than Daily Pills
2020-05-22
COVID-19
COVID-19: Moderna Registers Positive Phase 1 Results for mRNA Vaccine
2020-05-18
COVID-19 Anti-COVID Drug
Potential Repurposed Drugs Currently in Evaluation for COVID-19
2020-05-01
COVID-19 Remdesivir
COVID-19: Gilead’s Promising Remdesivir Data Jumps US Stocks, Hastens FDA’s Emergency Authorization Plans
2020-04-29
COVID-19 Vaccine
Weekly cover : Companies Developing 2019-nCoV Vaccine
2020-02-04
LATEST
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
Pharmacogenomics in Asia-Pacific: Nalagenetics CEO Levana Sani Offers Insights and Strategies
2024-04-17
READ MORE
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top